Short Interest in iShares Health Innovation Active ETF (NYSEARCA:BMED) Expands By 255.1%

iShares Health Innovation Active ETF (NYSEARCA:BMED) saw a significant increase in short interest in February. As of February 13th, there was short interest totaling 13,489 shares, an increase of 255.1% from the January 29th total of 3,799 shares. Based on an average daily trading volume, of 6,368 shares, the short-interest ratio is presently 2.1 days. Currently, 4.2% of the company’s stock are short sold. Currently, 4.2% of the company’s stock are short sold. Based on an average daily trading volume, of 6,368 shares, the short-interest ratio is presently 2.1 days.

iShares Health Innovation Active ETF Stock Up 0.9%

Shares of NYSEARCA:BMED traded up $0.28 on Friday, reaching $31.03. The company had a trading volume of 4,458 shares, compared to its average volume of 6,596. The stock has a market capitalization of $9.93 million, a P/E ratio of 24.91 and a beta of 0.84. The stock has a 50-day moving average price of $30.96 and a 200 day moving average price of $29.00. iShares Health Innovation Active ETF has a twelve month low of $20.57 and a twelve month high of $32.19.

Institutional Investors Weigh In On iShares Health Innovation Active ETF

An institutional investor recently bought a new position in iShares Health Innovation Active ETF stock. Sunbelt Securities Inc. purchased a new stake in iShares Health Innovation Active ETF (NYSEARCA:BMED) in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor purchased 11,612 shares of the company’s stock, valued at approximately $352,000. Sunbelt Securities Inc. owned 3.63% of iShares Health Innovation Active ETF at the end of the most recent reporting period.

iShares Health Innovation Active ETF Company Profile

The BlackRock Future Health ETF (BMED) is an exchange-traded fund that is based on the MSCI All Country World index. The fund is actively managed to invest in global equities in the health sciences industry. BMED was launched on Sep 29, 2020 and is managed by BlackRock.